Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.

The New England journal of medicine·2026
Same author

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.

Advances in therapy·2026
Same author

Complement 3 Glomerulopathy (C3G) in Native and Posttransplant Kidneys: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Complement biomarkers during iptacopan treatment - Authors' reply.

Lancet (London, England)·2026
Same author

Shared multicellular injury programs of acute and chronic kidney disease enable mechanistic patient stratification.

medRxiv : the preprint server for health sciences·2026
Same author

Precision Diagnosis in APOL1 Kidney Disease With the p.N264K M1 Protective Variant.

JAMA network open·2026

Related Experiment Video

Updated: May 20, 2026

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
09:12

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

Published on: January 18, 2019

C3 glomerulopathy: what's in a name?

Vivette D D'Agati, Andrew S Bomback

    Kidney International
    |August 1, 2012
    PubMed
    Summary

    Membranoproliferative glomerulonephritis (MPGN) classification now uses immunofluorescence. C3 glomerulopathy, defined by C3-only deposits, signifies complement pathway issues and requires differentiation from immunoglobulin-mediated MPGN for improved patient care.

    Area of Science:

    • Nephrology
    • Immunology
    • Complement System Biology

    Background:

    • Membranoproliferative glomerulonephritis (MPGN) classification historically relied on morphology.
    • Current understanding emphasizes immunofluorescence findings for MPGN classification.

    Purpose of the Study:

    • To highlight the shift towards immunofluorescence in MPGN classification.
    • To define C3 glomerulopathy as a distinct entity within MPGN.
    • To underscore the importance of differentiating C3 glomerulopathy from immunoglobulin-mediated MPGN.

    Main Methods:

    • Review of current diagnostic criteria for MPGN.
    • Analysis of immunofluorescence findings in glomerular diseases.
    • Comparison of C3 glomerulopathy with immunoglobulin-mediated MPGN.

    More Related Videos

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
    07:15

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

    Published on: August 23, 2024

    An Efficient and Fast Method for Labeling and Analyzing Mouse Glomeruli
    09:50

    An Efficient and Fast Method for Labeling and Analyzing Mouse Glomeruli

    Published on: February 9, 2024

    Related Experiment Videos

    Last Updated: May 20, 2026

    Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
    09:12

    Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins

    Published on: January 18, 2019

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
    07:15

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

    Published on: August 23, 2024

    An Efficient and Fast Method for Labeling and Analyzing Mouse Glomeruli
    09:50

    An Efficient and Fast Method for Labeling and Analyzing Mouse Glomeruli

    Published on: February 9, 2024

    Main Results:

    • Glomerular C3 deposits without immunoglobulin characterize C3 glomerulopathy.
    • C3 glomerulopathy encompasses dense deposit disease and C3 glomerulonephritis.
    • Distinguishing C3 glomerulopathy from immunoglobulin-mediated MPGN is crucial.

    Conclusions:

    • Modern MPGN classification relies on immunofluorescence, particularly C3 deposits.
    • C3 glomerulopathy represents a distinct group of diseases linked to complement dysregulation.
    • Accurate diagnosis of C3 glomerulopathy versus immunoglobulin-mediated MPGN improves patient management.